Filing Flows › Axogen (AXGN) › Recalls, complaints & regulation
Axogen (AXGN): clinical trials
Axogen (AXGN) beyond its filings: 3 active clinical trials.
Axogen's latest quarter
Axogen, Q3 2026: revenue $75.8M (+26% year over year), operating margin 1.3%, net earnings $2.3M, operating cash flow $16.5M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Axogen have?
3 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.